(Photo: iStock)

Bambuterol 10mg tablet, used in the treatment of asthma and chronic obstructive pulmonary disease, is facing supply disruption as sole supplier of the medicine, Astra Zeneca, is discontinuing its production, according to an update by the Department of Health and Social Care (DHSC).

The available stock of the medicine is expected to be exhausted by the end of June 2022.

Meanwhile, other oral β2-agonists, which are the preferred route of administration, remain available, DHSC said.

The department has already sent a copy of this medicine supply notification to all pharmacy NHS email addresses.

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY